CTI BioPharma Corp - Company Profile

Powered by

All the data and insights you need on CTI BioPharma Corp in one report.

  • Save hours of research time and resources with
    our up-to-date CTI BioPharma Corp Strategy Report

  • Understand CTI BioPharma Corp position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

CTI BioPharma Corp: Segment Analysis

Business Description

CTI BioPharma Corp (CTI BioPharma), a subsidiary of Swedish Orphan Biovitrum AB, focuses on the acquisition, development and commercialization of novel therapies for the treatment of a wide range of blood-related cancers. The company sole product candidate in active development stage is evaluated for the treatment of myelofibrosis for adult patients.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Start of HubSpot Embed Code End of HubSpot Embed Code